Synopsis of recent research by authors named "Shau-yin Ha"
- Shau-yin Ha's recent research primarily focuses on pediatric hematological malignancies, particularly acute myeloid leukemia (AML), and emphasizes optimized risk stratification and prognostic evaluations for KMT2A-rearranged cases, identifying new recurrent genetic fusions that may impact treatment outcomes.
- The author has contributed to understanding the complications arising from intensive therapy in pediatric populations, including therapy-related myeloid neoplasms in medulloblastoma patients and acute kidney injury in children undergoing treatment for hematological cancers, advocating for better surveillance and risk assessment.
- Recent studies illustrate Ha's commitment to advancing precision medicine through pharmacogenomic profiling and the development of molecular diagnostic tools, aiming to enhance therapeutic strategies and treatment personalization for pediatric patients suffering from acute myeloid leukemia and other blood disorders.
